Goblet Cell Adenocarcinoma of the Appendix (GCA) 

Goblet Cell Adenocarcinoma of the Appendix (GCA) 

Some of you may have seen an article published in the Mail Online (19th March) about a young mum, diagnosed with Goblet Cell Adenocarcinoma of the Appendix.   Our thoughts are with this young woman and her family. However, we would like to reduce any confusion or...
NETTER-2 Study Results: Looking Beyond The headlines.

NETTER-2 Study Results: Looking Beyond The headlines.

The latest breakthrough in neuroendocrine cancer treatment comes from the NETTER-2 trial, where Lutetium (177Lu) oxodotreotide, a radio-labeled somatostatin analog, has shown remarkable success in treating high-grade advanced gastroenteropancreatic neuroendocrine...
Unwind Your Mind: Join Our 8-Week Mindfulness Programme

Unwind Your Mind: Join Our 8-Week Mindfulness Programme

– Mindfulness for Managing Pain, Anxiety and Fatigue  In March 2023, our counselling and psychotherapy partners at RareMinds ran an Online (Zoom) taster session on ‘Mindfulness for Pain and Fatigue’ for our Neuroendocrine Cancer community. Following on from the...